• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ono Pharmaceutical

team layoffs workforce
Biotech

Ono Pharma lays off 83 staffers at Cambridge site

The affected Cambridge site is Ono’s U.S. headquarters and one of the company's two locations in the country, with the other in San Francisco.
Gabrielle Masson Apr 29, 2025 1:56pm
An artists 3D rendering of cancerous blood cells among healthy red blood cells The cells fill the image and are of various

Ono pays $280M upfront for Ionis' phase 2 blood cancer med

Mar 12, 2025 6:30am
An imaginary winners podium is modelled and rendered

Merck KGaA tumor trial hits goal, teeing up Daiichi, Ono rivalry

Nov 12, 2024 4:46am
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Ono inks $700M biobuck deal to bag preclinical LigaChem ADC

Oct 10, 2024 9:40am
pivot change turnaround direction walk away

Shattuck axes CD47 program, cuts 40% of staff over weak data

Oct 1, 2024 8:22am
A series of dice with a bag on them illustrating cost cuts

Cue lays off 25%, prioritizing preclinical autoimmune assets

Jul 26, 2024 4:29am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings